Clinical Trial Details
EORTC-1537-LYMG
Back to Clinical Trials Database
Very early FDG-PET-response adapted targeted therapy for advanced Hodgkin lymphoma: a single-arm phase II study
Trial Status | Closed to Patient Entry |
---|---|
Dates |
Date of activation: 30-Jul-2019 |
Data management at EORTC | Yes |
Design |
Phase 2 Not randomized / N.A. |
Targeted Sample size | EORTC Groups: 150 - All Groups: 150 |
Treatment |
Radiotherapy, Drug Cyclophosphamide, Dacarbazine, Doxorubicin, Etoposide, Vinblastine, Dexamethasone, Brentuximab vedotin |
Study Staff |
Martin Hutchings (Study Coordinator) , Rigshospitalet, Copenhagen Emanuel Buhrer (Project Physician) , EORTC Headquarters, Brussels Enrico Clementel (QART Manager) , EORTC Headquarters, Brussels Shani De Coster (Data Manager) , EORTC Headquarters, Brussels Terry Desmae (TR Manager) , EORTC Headquarters, Brussels Ruxandra Dionisie (Pharmacovigilance Manager) , EORTC Headquarters, Brussels Hazal Erkol (Data Manager) , EORTC Headquarters, Brussels Catherine Fortpied (Statistician) , EORTC Headquarters, Brussels Claire Gandilhon (Clinical Operations Assistant) , EORTC Headquarters, Brussels Hafida Lmalem (Imaging Officer) , EORTC Headquarters, Brussels Cedric Mallien (Clinical Operations Manager) , EORTC Headquarters, Brussels Zara Nasir (Pharmacovigilance Manager) , EORTC Headquarters, Brussels Sarah Nuyens (Project Manager) , EORTC Headquarters, Brussels Axelle Nzokirantevye (Imaging DM) , EORTC Headquarters, Brussels Miguel Remis (Lead CRA) , EORTC Headquarters, Brussels Ward Sents (Clinical Scientist) , EORTC Headquarters, Brussels Lucy Sepulveda (Regulatory Affairs Administrator) , EORTC Headquarters, Brussels Maarten Spruyt (Data Manager) , EORTC Headquarters, Brussels Jelle Stans (Regulatory Affairs Manager) , EORTC Headquarters, Brussels Bette Stofs (Pharmacovigilance Manager) , EORTC Headquarters, Brussels Leen Wijnen (Imaging DM) , EORTC Headquarters, Brussels Gaetan de Schaetzen (Senior Clinical Operations Manager) , EORTC Headquarters, Brussels |
Type of cancer | Hodgkins Disease |
Participating groups | EORTC Lymphoma Group |
Recruiting centers |
Amsterdam UMC - Locatie AMC (Amsterdam, Netherlands) Complejo Hospitalario de Navarra (Pamplona, Spain) Complejo Hospitalario de Navarra (Pamplona, Spain) Deventer Ziekenhuis (Deventer, Netherlands) Erasmus MC (Rotterdam, Netherlands) Erasmus MC (Rotterdam, Netherlands) Haaglanden MC - locatie Antoniushove ( Leidschendam, Netherlands) ICO L’Hospitalet - Hospital Duran i Reynals (Institut Catala D'Oncologia) (L' Hospitalet De Llobregat, Spain) Instituto Portugues de Oncologia de Lisboa Francisco Gentil – EPE (Lisboa, Portugal) Maria Sklodowska-Curie National Research Institute of Oncology (Warsaw, Poland) Maxima Medisch Centrum - Locatie Veldhoven (Veldhoven, Netherlands) Medisch Centrum Leeuwarden-Zuid (Leeuwarden, Netherlands) Narodny Onkologicky Ustav - Bratislava (Bratislava, Slovakia) Radboud University Medical Center Nijmegen (Nijmegen, Netherlands) Rigshospitalet (Copenhagen, Denmark) U.Z. Leuven - Campus Gasthuisberg (Leuven, Belgium) Universitair Ziekenhuis Antwerpen (Edegem, Belgium) University Medical Center Groningen (Groningen, Netherlands) ZNA CADIX (Antwerpen, Belgium) |
Protocol summary | http://clinicaltrials.gov/study/NCT03517137 |
NCT number | NCT03517137 |
EudraCT | 2017-000498-35 |
Financial Support | Educational Grant |